Liquid Biopsies – Multimedia

Isolating single cells is crucial in various research fields such as rare-cell analysis, biologics discovery and stem cell research. However, the process of identifying and isolating productive single cells remains a significant challenge, partly due to resource-intensive and often ineffective techniques like limiting dilution.

This infographic takes a look at some of the benefits that liquid biopsies can offer and explores examples of recent developments in this field.

Liquid biopsy for profiling of cell free DNA (cfDNA) in blood holds huge promise to transform how we experience and manage cancer by early detection and identification of residual disease and subtype. However, a standard blood draw yields an average of only 10 ng of cfDNA, of which DNA derived from the tumor is a small minority.

In this episode we discuss how the combination of both genetic and epigenetic information within a single DNA sample can provide key insights on the dynamic interactions that are occurring, offering significant advantages in many research areas.

In this Teach me in 10 episode we will explore how simultaneous sequencing of genetic and epigenetic bases in cfDNA allows for early cancer detection.

Analyzing nucleic acids provides insights into a variety of biological processes. However, the quality of your isolated DNA or RNA has a direct impact on the success of your genomic techniques and applications.

At various points throughout the NGS workflow, QC steps are recommended to avoid time and resource wasting, and to help prevent suboptimal sequencing data.

Download this infographic to learn about the importance of liquid biopsies and their use in cancer diagnosis and monitoring.

In this infographic, we delve into the field of cancer genetics, highlight key milestones and explore how genomic approaches are transforming diagnosis and treatment of the disease in the clinic.

Understanding the integrity and quantity of your nucleic acid samples is critical for next-generation sequencing (NGS) and biobanking workflows.